SciChart Wins Healthcare Tech of the Year at 2025 National Technology Awards
LONDON, July 12, 2025 (GLOBE NEWSWIRE) -- SciChart, the world's leading provider of high-performance charting and data visualization software, has been awarded Healthcare Tech of the Year at the 2025 National Technology Awards — one of the UK's most prestigious honors for technology innovation.
Run annually by National Technology News, the awards celebrate groundbreaking contributions across AI, healthtech, fintech, cybersecurity, and more. SciChart was selected from a competitive field of medtech innovators for its pivotal role in enabling real-time clinical decisions in some of healthcare's most demanding environments — from neurorehabilitation and surgical platforms to large-scale telehealth deployments.
'This award recognizes a silent but powerful revolution,' said Andrew Burnett-Thompson, CEO and Founder of SciChart. 'Medical technology is only as useful as the decisions it enables. With SciChart, we're helping clinicians and researchers around the world make faster, safer, smarter decisions — when seconds matter most.'
Driving the Future of Data-Driven Care
In an era where precision and speed are paramount, SciChart is redefining the possibilities for medical interfaces, driving innovation from operating rooms to rehabilitation labs and critical care dashboards.
Real-Time Recovery for Motor-Impaired Patients
In advanced neurorehabilitation trials, SciChart enabled real-time visualization of muscle activity, kinematic movement, and neural stimulation — all on a single interface. This allowed clinicians to align stimulation with patient motion dynamically, contributing to patients regaining voluntary movement within days.
Advanced Imaging and Diagnostics
For cutting-edge clinical applications like ultrafast laser data and fluorescence capture, SciChart slashed rendering delays from 20 minutes to under 2 seconds. This unparalleled speed empowers surgeons to make immediate intraoperative decisions using live feedback and AI-generated signal analysis.
'SciChart delivered the speed and performance we needed to handle complex, high-resolution medical data — something our previous tools just couldn't keep up with.' – Head of Innovation, Surgical Technology Company
Scalable Telehealth Across 5,000+ Patients
One of the world's leading medical technology providers deployed SciChart to power real-time patient monitoring across 25 hospitals — enabling clinicians to respond faster to critical events and improving care for over 5,000 patients daily. Custom dashboards enabled clinicians to spot anomalies instantly, while streamlined workflows improved operational efficiency across hospital networks.
Powering the Interface Between AI and Action
As AI reshapes diagnostics and intervention, it creates a new challenge: delivering insights in real time, clearly and reliably. SciChart provides the high-performance visualization layer that bridges the gap between algorithmic output and clinical action — enabling live, data-rich user interfaces in surgery, diagnostics, and remote care.
Unlike generic charting libraries, SciChart is purpose-built specifically for demanding, real-time medical applications, seamlessly transforming abstract data into clinically actionable insights. From live kinematic visualizations to fluorescence overlays, SciChart is the silent engine behind the next generation of healthcare technology.
About SciChart
Founded in 2010, SciChart provides the world's fastest, most flexible data visualization libraries. Trusted across industries where performance is paramount — including healthcare, finance, energy, and scientific research — SciChart empowers critical decision-making. Learn more at www.scichart.com.
Press ContactAlicja RadwanskaChief Marketing Officer, SciChartalicja@scichart.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c0f21381-3988-455d-a1dc-1a565812a315
Videos accompanying this announcement are available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/66d122f6-d895-446e-8742-1b77f54d1d8e https://www.globenewswire.com/NewsRoom/AttachmentNg/5836734c-34c3-4249-87c8-c4fe1bbbd342
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
2 hours ago
- Washington Post
A London music festival cancels its final night after ELO's Jeff Lynne pulls out
LONDON — A two-week-long music festival in central London has cancelled its final night after Jeff Lynne's Electric Light Orchestra pulled out of the headline slot on Sunday. Lynne, 77, who was billed to play alongside his band Sunday at the The BST Hyde Park festival, withdrew on Saturday on the advice of doctors as a result of what was termed a 'systemic infection.'
Associated Press
2 hours ago
- Associated Press
The UN warns millions will die by 2029 if US funding for HIV programs isn't replaced
LONDON (AP) — Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest levels seen in more than three decades and provided life-saving medicines for some of the world's most vulnerable. But in the last six months, the sudden withdrawal of U.S. money has caused a 'systemic shock,' U.N. officials warned, adding that if the funding isn't replaced, it could lead to more than 4 million AIDS-related deaths and 6 million more HIV infections by 2029. A new UNAIDS report released Thursday said the funding losses have 'already destabilized supply chains, led to the closure of health facilities, left thousands of health clinics without staff, set back prevention programs, disrupted HIV testing efforts and forced many community organizations to reduce or halt their HIV activities.' It also said that it feared other major donors scaled back their support, reversing decades of progress against AIDS worldwide — and that the strong multilateral cooperation is in jeopardy because of wars, geopolitical shifts and climate change. A 'lifeline' removed AP AUDIO: UN says if US funding for HIV programs is not replaced, millions more will die by 2029 AP correspondent Karen Chammas reports on the impact of cuts to US funding for international HIV programs. The $4 billion that the United States pledged for the global HIV response for 2025 disappeared virtually overnight in January, when U.S. President Donald Trump ordered that all foreign aid be suspended and later moved to shutter the U.S. AID agency. Andrew Hill, an HIV expert at the University of Liverpool who is not connected to the United Nations, said that while Trump is entitled to spend U.S. money as he sees fit, 'any responsible government would have given advance warning so countries could plan,' instead of stranding patients in Africa where clinics were closed overnight. The U.S. President's Emergency Plan for AIDS Relief, or PEPFAR, was launched in 2003 by U.S. President George W. Bush, the biggest-ever commitment by any country focused on a single disease. UNAIDS called the program a 'lifeline' for countries with high HIV rates, and said that it supported testing for 84.1 million people, treatment for 20.6 million, among other initiatives. According to data from Nigeria, PEPFAR also funded 99.9% of the country's budget for medicines taken to prevent HIV. U.N. Assistant Secretary-General Angeli Achrekar, a UNAIDS deputy executive director who was PEPFAR's principal deputy coordinator until January 2023, said the program is under review by the Trump administration though Secretary of State Marco Rubio issued a waiver 'to continue life-saving treatment.' ''The extent to which it will continue in the future, we don't know,' she told a video news conference with U.N. reporters in New York. 'We are cautiously hopeful that PEPFAR will continue to support both prevention and treatment services.' A gap impossible to fill In 2024, there were about 630,000 AIDS-related deaths worldwide, per a UNAIDS estimate — the figure has remained about the same since 2022 after peaking at about 2 million deaths in 2004. Even before the U.S. funding cuts, progress against curbing HIV was uneven. UNAIDS said that half of all new infections are in sub-Saharan Africa. Tom Ellman of Doctors Without Borders said that while some poorer countries were now moving to fund more of their own HIV programs, it would be impossible to fill the gap left by the U.S. 'There's nothing we can do that will protect these countries from the sudden, vicious withdrawal of support from the U.S.,' said Ellman, head of the group's South Africa medical unit. Experts also fear another significant loss — data. The U.S. paid for most HIV surveillance in African countries, including hospital, patient and electronic records, all of which has now abruptly ceased, according to Dr. Chris Beyrer, director of the Global Health Institute at Duke University. 'Without reliable data about how HIV is spreading, it will be incredibly hard to stop it,' he said. A new drug revives hope The uncertainty comes in the wake of a twice-yearly injectable that many hope could end HIV. Studies published last year showed that the drug from pharmaceutical maker Gilead was 100% effective in preventing the virus. At a launch event Thursday, South Africa's health minister Aaron Motsoaledi said the country would 'move mountains and rivers to make sure every adolescent girl who needs it will get it,' saying that the continent's past dependence upon US aid was 'scary.' Last month, the U.S. Food and Drug Administration approved the drug, called Yeztugo, a move that should have been a 'threshold moment' for stopping the AIDS epidemic, said Peter Maybarduk of the advocacy group Public Citizen. But activists like Maybarduk said Gilead's pricing will put it out of reach of many countries that need it. Gilead has agreed to sell generic versions of the drug in 120 poor countries with high HIV rates but has excluded nearly all of Latin America, where rates are far lower but increasing. 'We could be ending AIDS,' Maybarduk said. 'Instead, the U.S. is abandoning the fight.' ___ ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP receives financial support for global health and development coverage in Africa from the Gates Foundation. The AP is solely responsible for all content. Find AP's standards for working with philanthropies, a list of supporters and funded coverage areas at ___
Forbes
2 hours ago
- Forbes
Meta And OpenAI's Talent Wars: How AI Mints Elites But Displaces Others
The Meta AI logo is displayed on a mobile phone with the Meta logo visible on a tablet in this photo ... More illustration in Brussels, Belgium, on January 26, 2025. (Photo by Jonathan Raa/NurPhoto via Getty Images) The AI talent war has escalated into a white-hot race. After Meta's poaching spree, OpenAI hired Tesla's former VP of software engineering David Lau and xAI's infrastructure architects Uday Ruddarraju and Mike Dalton, who built xAI's 200,000-GPU Colossus supercomputer. With Meta deploying recruits to its Superintelligence Lab and hiring Apple's Foundation Models lead Ruoming Pang with over $200 million package, elite talent and computing power have become existential currencies. This fierce competition means a dichotomy of AI's impact on the workforce. While companies dangle nine-figure salaries for top AI talents, mass layoffs may continue across the tech industry. Impacted roles not only include human resources and customer service, but increasingly software development and middle-level management positions. Talent Wars: History Reverberates This AI hiring frenzy mirrors Microsoft and Google's intense 'war for talent' in the 2000s, triggered by Google's disruptive rise. Google's focus on the internet's transformative potential lured some of the brightest engineers, forcing Microsoft to overhaul hiring and retention strategies. In 2005, when Microsoft sued Google after executive Kai-Fu Lee departed Microsoft to join Google, symbolizing the battle for technical visionaries and Google's aggressive recruitment tactics. Beyond talent, Microsoft and Google clashed directly in web technologies. While Microsoft dominated browsers with Internet Explorer, Google's superior page rank algorithm made it the search leader. Crucially, Microsoft's early search project Keywords was shut down over revenue-cannibalization fears, ceding the ad-search market to Google. This reflected a broader contrast, Google's simplicity and teamwork efficiency in its user interface such as Google Docs and appealed to evolving users, while Microsoft's complex legacy interfaces struggled against the web's disruptive momentum. But today, Google Chrome and Google search face unprecedented challenges from OpenAI as the latter announced the release of its own browser soon. The Scarcity of Top AI Talent Competition centers on specialized AI researchers from elite PhD programs with machine learning backgrounds and veterans who already spearheaded key innovations in top companies. Meta's recruitment of Scale AI founder Alexandre Wang and a dozen of OpenAI and Deepmind veterans crystalizes the trend, signaling heavy investment in future AI directions: advanced reasoning (hiring OpenAI's Hongyu Ren), multimodal systems (hiring OpenAI's Huiwen Chang and DeepMind's Jack Rae), LLM infrastructure, and AI agents (hiring OpenAI's Trapit Bansal). Perhaps no more than a few hundreds of AI top talents worldwide possess this caliber of expertise, a scarcity inflating salaries to star levels while reducing the job prospect of software engineers whose programming skills can be automated. Alumni from OpenAI, Meta, and DeepMind, including Ilya Sutskever (founder of Safe Superintelligence), Mira Murati and Lilian Weng (founders of Thinking Machines Lab), fuel new ventures, but cash-rich giants destabilize them through financial overpowering. Paradoxically, this talent churn risks homogenizing core AI technologies as ideas circulate within a tightly knit talent web. Sustainable breakthroughs now depend on defining new problem frontiers, and developing new AI applications with built in domain expertise ranging from medicine, science, finance, law, coding, marketing and sales, and not refining existing models. For instance, the biomedicine AI start-up Arc Institute is designing a machine learning model trained on DNA of 100,000 species to identify disease-causing genome mutations and to assist new drug discovery. The Layoff Paradox While tech giants court AI stars, the industry has cut more than 150,000 jobs since 2023. Microsoft's 9,100 engineer-targeted cuts and Intel's planned 20% reduction contrast with the industry's $40billion+ in AI investments this year. As Nvidia CEO Jensen Huang acknowledges, AI now automates coding, analysis, and strategy, erasing roles these companies once prized. The World Economic Forum's 2025 Job Report projects 92 million job displacements versus 170 million new roles, demanding the workforce's urgent adaptation to automated technologies. Growth sectors will prioritize physical labor (construction), emotional intelligence (elderly care), robotics (physical intelligence), and sustainability, fields where AI complements rather than replaces humans. Notably, technological literacy and creative resilience will outpace coding skills in value by 2030. Universities must prepare students by updating the computer science curricula to focus on deep learning, reinforcement learning, multimodal AI and AI infrastructure design, among other skills in demand on the tech job market. We face extraordinary challenges of a bifurcated future, echoing early internet talent wars with exponentially higher stakes. As elite researchers command overflowing compensation, mid-career technologists confront obsolescence. Companies racing toward AGI must answer a moral question: Can we reskill populations at AI's disruptive pace, or will displacement ignite social upheaval? The answer will define our century more profoundly than any model.
